Table 3.
Always depressed versus never depressed**
|
p-value | |||
---|---|---|---|---|
Rate Ratio (95% CI) | ||||
From Normal at Baseline to MCI*** | ||||
Always depressed during follow-up | 2.35 | 1.86 | 2.96 | <0.0001 |
Depressed at 1st visit but later not depressed | 1.41 | 1.01 | 1.95 | 0.04 |
Intermittent depression over follow-up | 2.22 | 1.86 | 2.65 | <0.0001 |
Prior history of depression | 1.00 | 0.81 | 1.23 | 0.99 |
Antidepressant**** | ||||
SSRI | 1.22 | 0.98 | 1.51 | 0.08 |
Non-selective/Other | 1.17 | 0.93 | 1.48 | 0.17 |
From MCI at baseline to AD*** | ||||
Always depressed during follow-up | 1.21 | 1.00 | 1.46 | 0.06 |
Depressed after 1st visit but later not depressed | 0.86 | 0.64 | 1.16 | 0.33 |
Intermittent depression over follow-up | 1.15 | 0.97 | 1.37 | 0.11 |
Prior history of depression | 0.96 | 1.04 | 0.89 | 0.66 |
Antidepressant**** | ||||
SSRI | 1.38 | 1.17 | 1.63 | 0.0001 |
Non-selective/other | 1.25 | 1.03 | 1.52 | 0.02 |
All models adjusted for age, gender, race, education, history of stroke/transient ischemic attack (TIA), history of diabetes, four cognitive tests (MMSE, logical memory, category fluency, WAIS), and functional activity (FAQ). Data for missing values imputed.
depression defined as either current or in the last 2 years.
5,607 (883 transitioned) individuals in analysis from normal to worse, 2,500 (856 transitioned) individuals in analysis from MCI to AD.
Drugs are time-dependent, considered at time of failure of each index case.